SB 17 - This act requires practitioners, before an initial opioid prescription and the third in a course of treatment, to consult with the patient as to the risks of taking opioids and alternatives to opioids. The practitioner shall make note of the consultation in the patient's medical record. The provisions of this act shall not apply to those in hospice or palliative care, in a long-term care facility, or receiving treatment for cancer, substance abuse, or opioid dependence.

This act is identical to SB 943 (2024) and SB 673 (2023) and substantially similar to a provision in SS/SB 830 (2024).

SARAH HASKINS

Statutes affected:
Introduced (0105S.01): 195.080

---

Senate Committee Minutes:
SENATE COMMITTEE MINUTES Bill No.: SB 17
Sponsor: May
Hearing Date: 3/5/2025


COMMITTEE: Families, Seniors and Health

CHAIRMAN: Carter

DATE REFERRED: 1/16/2025 DATE HEARING REQUESTED:



STAFF:
Sarah Haskins
Heidi Kolkmeyer
Dennis Rhodes
Blake Thompson


WITNESSES GIVING INFORMATION:



WITNESSES FOR:
Eapen Thampy - Shaman Pharmaceuticals


WITNESSES AGAINST:
Mary Cremer